1. Dong, Yanru, Wen, Weibo, Yuan, Tiezheng, Liu, Lan, Li, Xiangdan. 2023. RILPL2 is associated with the progression and prognosis of cervical squamous cell carcinoma and endocervical adenocarcinoma. In American journal of translational research, 15, 1072-1084. doi:. https://pubmed.ncbi.nlm.nih.gov/36915776/
2. Liu, Jinhui, Xu, Mengting, Wu, Zhipeng, Liang, Jianqiang, Zhu, Hongjun. 2021. Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma. In Frontiers in molecular biosciences, 8, 670893. doi:10.3389/fmolb.2021.670893. https://pubmed.ncbi.nlm.nih.gov/34095226/
3. Lisé, Marie-France, Srivastava, Deepak P, Arstikaitis, Pamela, O'Connor, Timothy P, El-Husseini, Alaa. . Myosin-Va-interacting protein, RILPL2, controls cell shape and neuronal morphogenesis via Rac signaling. In Journal of cell science, 122, 3810-21. doi:10.1242/jcs.050344. https://pubmed.ncbi.nlm.nih.gov/19812310/
4. Gao, Qianwen, Wang, Xin, Zhang, Yue, Xu, Caigang, Zheng, Yuhuan. 2024. Ferroptosis-related prognostic model of mantle cell lymphoma. In Open medicine (Warsaw, Poland), 19, 20241090. doi:10.1515/med-2024-1090. https://pubmed.ncbi.nlm.nih.gov/39588389/
5. Steger, Martin, Diez, Federico, Dhekne, Herschel S, Alessi, Dario R, Mann, Matthias. 2017. Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis. In eLife, 6, . doi:10.7554/eLife.31012. https://pubmed.ncbi.nlm.nih.gov/29125462/
智鼠故事 
